Docoh
Loading...

PRPH ProPhase Labs

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products and dietary supplements. Its products include TK supplement. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Doylestown, PA.

Company profile

Ticker
PRPH
Exchange
CEO
Ted William Karkus
Employees
Incorporated
Location
Fiscal year end
Former names
QUIGLEY CORP
SEC CIK
IRS number
232577138

PRPH stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

31 Mar 21
13 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 6.82M 6.82M 6.82M 6.82M 6.82M 6.82M
Cash burn (monthly) 1.35M (positive/no burn) 257.67K 174.42K 528K (positive/no burn)
Cash used (since last report) 4.64M n/a 887.17K 600.53K 1.82M n/a
Cash remaining 2.17M n/a 5.93M 6.22M 5M n/a
Runway (months of cash) 1.6 n/a 23.0 35.6 9.5 n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
10 Sep 20 Warren Hirsch Option Common Stock Grant Aquire A No No 2.83 50,000 141.5K 50,000
10 Sep 20 Gleckel Louis MD Option Common Stock Grant Aquire A No No 2.83 100,000 283K 100,000
10 Sep 20 Barr Jason Michael Option Common Stock Grant Aquire A No No 2.83 50,000 141.5K 50,000
16 Aug 20 Monica L. Brady Option Common Stock Grant Aquire A No No 2.64 150,000 396K 150,000
13 Aug 20 Karkus Ted William Common Stock, par value $0.005 Sell Dispose S No No 2.75 50,000 137.5K 2,419,528

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

3.1% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 15 13 +15.4%
Opened positions 5 1 +400.0%
Closed positions 3 2 +50.0%
Increased positions 6 2 +200.0%
Reduced positions 2 6 -66.7%
13F shares
Current Prev Q Change
Total value 4.37M 1.62M +169.8%
Total shares 475.63K 467.75K +1.7%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Renaissance Technologies 275.01K $2.53M +25.3%
Vanguard 63.29K $581K +50.2%
NTRS Northern Trust 46.48K $426K +14.5%
Geode Capital Management 26.66K $244K NEW
BK Bank Of New York Mellon 24.27K $223K -79.1%
Commonwealth Equity Services 17.94K $164K +5.9%
Capstone Investment Advisors 11.96K $110K NEW
Tower Research Capital 2.97K $28K NEW
MS Morgan Stanley 2.33K $21K +174.1%
Dorsey Wright & Associates 1.36K $12K NEW
Largest transactions
Shares Bought/sold Change
BK Bank Of New York Mellon 24.27K -92.02K -79.1%
Renaissance Technologies 275.01K +55.5K +25.3%
Geode Capital Management 26.66K +26.66K NEW
PNC PNC Financial Services 0 -25.4K EXIT
Vanguard 63.29K +21.17K +50.2%
Capstone Investment Advisors 11.96K +11.96K NEW
NTRS Northern Trust 46.48K +5.87K +14.5%
UBS UBS Group AG - Registered Shares 1.12K -3.98K -78.0%
Tower Research Capital 2.97K +2.97K NEW
MS Morgan Stanley 2.33K +1.48K +174.1%

Financial report summary

?
Management Discussion
  • Net sales for Fiscal 2020 increased $4.6 million to $14.5 million as compared to $9.9 million for Fiscal 2019. The increase in net sales for Fiscal 2020 as compared to Fiscal 2019 is principally due to increased third party customer orders in contract manufacturing and revenue of $1.3 million related to our new diagnostic services business.
  • Cost of sales for Fiscal 2020 were $9.9 million as compared to $7.3 million for Fiscal 2019. We realized a gross profit $4.6 million for Fiscal 2020 as compared to $2.6 million for Fiscal 2019. For Fiscal 2020, our gross margin was 31.8% as compared to 26.5% for Fiscal 2019. Such increase in gross margin for Fiscal 2020 as compared to Fiscal 2019 is principally due to (i) an increase in the absorption of fixed production costs and (ii) fluctuations in our product mix and pricing fluctuations from period to period and increased margins generally associated with the new diagnostic services business. Gross margins have historically been influenced by fluctuations in quarter-to-quarter production volume, fixed production costs and related overhead absorption, raw ingredient costs, inventory mark to market write-downs and timing of shipments to customers.
  • Sales and marketing expense for Fiscal 2020 was $1.3 million as compared to $1.0 million for Fiscal 2019. The increase in sales and marketing expenses of $245,000 was related to an increase in advertising expenses for our retail consumer products and the new diagnostic services business.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: abatement, abuse, ACA, academic, accreditation, accredited, acid, ADLT, Advisory, advocacy, aggressive, aggressively, Aid, air, alcohol, allegedly, alleviate, alter, AMA, ancillary, Arvind, assembled, attack, Avenue, ballot, began, belonging, bind, blood, borrow, borrower, borrowing, breadth, BRG, Bridge, broader, brokering, bullet, cancel, CDLT, CHIP, choose, clarification, clarifying, CLIA, CMP, CMS, CODM, cohesive, compliant, compromised, confidential, confidentiality, confirm, construction, convenient, conversion, conveyance, coordinate, coordinated, coordination, courtesy, COVID, CPM, CPPA, CPRA, CPT, creation, culminating, culture, cure, cured, cut, deciding, Decision, default, denied, deny, Department, device, diagnostic, discharge, Dismissal, dismissed, disorder, disposal, dispose, dissolve, distancing, distract, divert, divestment, driver, duration, ease, effort, EisnerAmper, EKRA, emphasize, encourage, encryption, enrollment, enumeration, environment, environmental, EUA, exclusion, exclusively, extremely, face, facilitate, facilitating, facsimile, fact, family, fault, field, fine, finite, fit, floor, foot, forma, Fort, fostering, Foundation, Friedman, Garden, genetic, gradual, ground, Gurnani, harbor, healthy, HHS, HIPAA, HITECH, holder, home, HPID, identity, impede, implicate, implicit, impossible, imprisonment, improper, inability, incentivizing, inconsistent, induce, intangible, Interpace, Jersey, Justice, kind, kit, knowingly, knowledge, lab, labor, laboratory, land, Landlord, landscape, language, legislature, Lenape, liable, liberally, licensure, lived, LLP, Maker, mandate, mandating, median, Medicaid, Medicare, mental, methodology, minimal, moderate, molecular, multiple, multispecialty, nasal, necessarily, NJ, NPI, NPRM, NY, offense, OIG, Opioid, outsource, outsourced, owner, PA, PAMA, pandemic, panel, pari, partially, passu, pathogen, patient, patronage, payer, payor, PCR, people, phasing, PHI, physician, pickup, Plaza, Portability, post, preempted, preliminary, prepay, prepayment, Pride, prison, pro, Procedural, prompt, prosecution, prosecutorial, punctually, Quest, qui, real, recipient, recommended, recommending, recoup, recruiting, referral, refund, rehabilitation, reinvesting, relocated, remittance, remuneration, rent, repaid, repayment, representation, rescinding, residual, respiratory, retention, revalidation, revocation, RFI, RPP, rulemaking, saliva, SAMHSA, sample, sanction, screening, scrutiny, segment, Seller, sentence, small, social, soliciting, specimen, Spectrum, staffing, Stark, Stewart, stringent, substance, succeed, Sunshine, surveillance, suspected, swab, talent, tam, teaching, Terminology, thereon, thirty, thrive, transmission, transmitted, transport, transportation, travel, treat, tribunal, Trump, unaudited, underwriting, unique, unpaid, unrelated, unsecured, vaccination, Valley, valuable, viability, vii, viii, viral, waived, waste, willfully, windup, workforce, wrongful, York
Removed: acquirer, affiliated, announcement, asserted, awaiting, awarded, banking, bargaining, begun, brokerage, Bulletin, calculated, clearing, climate, collective, complementary, confidence, constituted, consummate, consummating, court, creating, damaged, declaring, disburse, discontinue, distributed, economy, enhance, exact, exempt, exemption, exercising, favorable, flagship, gluconate, hold, impacting, individually, inInternal, instability, installment, integrate, integration, intention, launch, LP, main, mutual, Opportunity, oral, PDM, prostaflow, prostate, pursuing, registering, registration, resale, Retreat, Road, salary, securitization, Shady, single, spray, strength, subscription, Super, Supplements®product, trend, unconsolidated, unemployment, union, unknown, urinary, voluntarily, voluntary, XL®to, zinc